A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
Sooriakumaran, P, Macanas-Pirard, P, Bucca, G, Henderson, A, Langley, SE, Laing, RW, Smith, CP, Laing, EE and Coley, HM (2009) A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. Cancer Genomics Proteomics, 6 (2). pp. 93-99.
Available under License : See the attached licence file.
We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis.
|Divisions :||Faculty of Health and Medical Sciences > School of Biosciences and Medicine > Department of Microbial and Cellular Sciences|
|Date :||March 2009|
|Uncontrolled Keywords :||Base Sequence, Cyclooxygenase Inhibitors, DNA Primers, DNA, Complementary, Gene Expression Profiling, Humans, Male, Oligonucleotide Array Sequence Analysis, Polymerase Chain Reaction, Prostatic Neoplasms, Pyrazoles, Single-Blind Method, Sulfonamides|
|Additional Information :||Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. Reproduced here by permission of the publisher.|
|Depositing User :||Symplectic Elements|
|Date Deposited :||23 Apr 2012 08:43|
|Last Modified :||23 Sep 2013 19:11|
Actions (login required)
Downloads per month over past year